Last reviewed · How we verify
Infusion of Donor Hematopoietic Stem Cells and Campath-1H — Competitive Intelligence Brief
phase 1
Biologic
Live · refreshed every 30 min
Target snapshot
Infusion of Donor Hematopoietic Stem Cells and Campath-1H (Infusion of Donor Hematopoietic Stem Cells and Campath-1H) — Northwestern University.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Infusion of Donor Hematopoietic Stem Cells and Campath-1H TARGET | Infusion of Donor Hematopoietic Stem Cells and Campath-1H | Northwestern University | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Infusion of Donor Hematopoietic Stem Cells and Campath-1H CI watch — RSS
- Infusion of Donor Hematopoietic Stem Cells and Campath-1H CI watch — Atom
- Infusion of Donor Hematopoietic Stem Cells and Campath-1H CI watch — JSON
- Infusion of Donor Hematopoietic Stem Cells and Campath-1H alone — RSS
Cite this brief
Drug Landscape (2026). Infusion of Donor Hematopoietic Stem Cells and Campath-1H — Competitive Intelligence Brief. https://druglandscape.com/ci/infusion-of-donor-hematopoietic-stem-cells-and-campath-1h. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab